CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 178 enrolled
Drug / intervention
Coffeedietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03712891
NCT03712891N/ACompleted
CompareCT.gov

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

TriHealth Inc.·interventional·Posted Oct 19, 2018·Updated Dec 13, 2024

In Brief

A clinical study evaluating Coffee for PACU Length of Stay and 3 related conditions. Completed, enrolled 178 participants across 1 site.

Detailed Summary

The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPACU Length of Stay, Postoperative Nausea, Postoperative Vomiting, Patient Satisfaction
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 19, 2018
Enrollment StartOct 25, 2018
Primary CompletionJul 1, 2023
Study CompletionAug 16, 2023
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 7.7 years ago

Interventions

Coffeedietary

Patients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)